TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs62402013
log Bayes Factor = 59.9927
Chromosome 6   position 26,915,000  (GRCh37) Explore rs62402013 on Ensembl!
Variant rs62402013 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E83.1 Disorders of iron metabolism
1.000 0.000 0.000
K90.0 Coeliac disease
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
E10.9 Without complications
0.000 0.000 1.000
E10-E14 Diabetes mellitus
0.000 0.000 1.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.000 1.000
E16.2 Hypoglycaemia, unspecified
0.000 0.001 0.999
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.001 0.999
E16 Other disorders of pancreatic internal secretion
0.000 0.001 0.999
E00-E07 Disorders of thyroid gland
0.000 0.003 0.997
E03 Other hypothyroidism
0.000 0.004 0.996
E03.9 Hypothyroidism, unspecified
0.000 0.004 0.996
N40 Hyperplasia of prostate
0.995 0.005 0.000
K90 Intestinal malabsorption
0.000 0.031 0.969
E10.3 With ophthalmic complications
0.000 0.048 0.952
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.060 0.940
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.060 0.940
E10.1 With ketoacidosis
0.000 0.065 0.935
K90.9 Intestinal malabsorption, unspecified
0.000 0.080 0.920
E14 Unspecified diabetes mellitus
0.000 0.109 0.891
E20-E35 Disorders of other endocrine glands
0.000 0.136 0.864
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.136 0.864
E10.7 With multiple complications
0.000 0.149 0.851
E10.2 With renal complications
0.000 0.166 0.834
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.166 0.834
E05.9 Thyrotoxicosis, unspecified
0.000 0.170 0.830
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.184 0.816
E27 Other disorders of adrenal gland
0.000 0.185 0.815
E10.5 With peripheral circulatory complications
0.000 0.186 0.814
E13 Other specified diabetes mellitus
0.000 0.209 0.791
E27.1 Primary adrenocortical insufficiency
0.000 0.217 0.783
E14.5 With peripheral circulatory complications
0.000 0.242 0.758
E14.1 With ketoacidosis
0.000 0.243 0.757
E10.8 With unspecified complications
0.000 0.252 0.747
E10.4 With neurological complications
0.000 0.270 0.730
E14.3 With ophthalmic complications
0.000 0.273 0.727
E14.6 With other specified complications
0.000 0.274 0.726
E40-E46 Malnutrition
0.000 0.277 0.723
E10.0 With coma
0.000 0.278 0.722
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.717
E15 Nondiabetic hypoglycaemic coma
0.000 0.283 0.717
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.283 0.716
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.283 0.716
E16.4 Abnormal secretion of gastrin
0.000 0.283 0.716
E16.3 Increased secretion of glucagon
0.000 0.283 0.716
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.285 0.715
E00 Congenital iodine-deficiency syndrome
0.000 0.285 0.715
E03.5 Myxoedema coma
0.000 0.286 0.714
E03.4 Atrophy of thyroid (acquired)
0.000 0.286 0.714
E03.3 Postinfectious hypothyroidism
0.000 0.286 0.714
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.290 0.710
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.293 0.707
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.300 0.700
K90.3 Pancreatic steatorrhoea
0.000 0.305 0.695
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.305 0.695
K90.1 Tropical sprue
0.000 0.305 0.695
E31 Polyglandular dysfunction
0.000 0.306 0.694
E10.6 With other specified complications
0.000 0.309 0.690
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.320 0.680
E05.5 Thyroid crisis or storm
0.000 0.326 0.674
E05.4 Thyrotoxicosis factitia
0.000 0.326 0.674
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.326 0.674
E21.0 Primary hyperparathyroidism
0.000 0.329 0.671
R31 Unspecified haematuria
0.671 0.329 0.000
E25 Adrenogenital disorders
0.000 0.336 0.664
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.337 0.663
E14.4 With neurological complications
0.000 0.339 0.661
E03.8 Other specified hypothyroidism
0.000 0.340 0.660
E13.9 Without complications
0.000 0.341 0.659
E07 Other disorders of thyroid
0.000 0.348 0.652
E14.0 With coma
0.000 0.358 0.642
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.358 0.642
E14.7 With multiple complications
0.000 0.361 0.639
E14.2 Withrenal complications
0.000 0.364 0.636
E16.1 Other hypoglycaemia
0.000 0.366 0.633
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.367 0.633
E24 Cushing's syndrome
0.000 0.367 0.633
E14.8 With unspecified complications
0.000 0.371 0.628
E22 Hyperfunction of pituitary gland
0.000 0.380 0.620
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.380 0.619
E32 Diseases of thymus
0.000 0.380 0.619
E30 Disorders of puberty, not elsewhere classified
0.000 0.380 0.619
K90.8 Other intestinal malabsorption
0.000 0.391 0.609
E27.2 Addisonian crisis
0.000 0.403 0.597
E27.5 Adrenomedullary hyperfunction
0.000 0.415 0.585
E27.0 Other adrenocortical overactivity
0.000 0.415 0.585
E34 Other endocrine disorders
0.000 0.419 0.581
E20 Hypoparathyroidism
0.000 0.424 0.576
E31.0 Autoimmune polyglandular failure
0.000 0.427 0.573
E26 Hyperaldosteronism
0.000 0.431 0.569
E13.8 With unspecified complications
0.000 0.433 0.567
E13.7 With multiple complications
0.000 0.433 0.567
E13.6 With other specified complications
0.000 0.433 0.567
E13.5 With peripheral circulatory complications
0.000 0.433 0.567
E13.4 With neurological complications
0.000 0.433 0.567
E13.2 With renal complications
0.000 0.433 0.567
E13.1 With ketoacidosis
0.000 0.433 0.567
E13.0 With coma
0.000 0.433 0.567
E50-E64 Other nutritional deficiencies
0.000 0.441 0.559
E21.4 Other specified disorders of parathyroid gland
0.000 0.455 0.545
E13.3 With ophthalmic complications
0.000 0.463 0.537
E22.1 Hyperprolactinaemia
0.000 0.466 0.534
E24.2 Drug-induced Cushing's syndrome
0.000 0.467 0.533
E03.1 Congenital hypothyroidism without goitre
0.001 0.468 0.531
E46 Unspecified protein-energy malnutrition
0.000 0.476 0.524
E05.8 Other thyrotoxicosis
0.000 0.476 0.523
E23 Hypofunction and other disorders of pituitary gland
0.000 0.477 0.523
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.479 0.520
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.482 0.518
E45 Retarded development following protein-energy malnutrition
0.000 0.482 0.518
E43 Unspecified severe protein-energy malnutrition
0.000 0.482 0.518
E42 Marasmic kwashiorkor
0.000 0.482 0.518
E41 Nutritional marasmus
0.000 0.482 0.518
E40 Kwashiorkor
0.000 0.482 0.518
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.487 0.513
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.487 0.513
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.487 0.513
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.487 0.513
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.487 0.513
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.487 0.513
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.487 0.513
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.487 0.513
E31.9 Polyglandular dysfunction, unspecified
0.000 0.502 0.498
E31.8 Other polyglandular dysfunction
0.000 0.502 0.498
E31.1 Polyglandular hyperfunction
0.000 0.502 0.498
E28 Ovarian dysfunction
0.000 0.505 0.495
E25.9 Adrenogenital disorder, unspecified
0.000 0.524 0.476
E25.8 Other adrenogenital disorders
0.000 0.524 0.476
E06 Thyroiditis
0.000 0.527 0.472
E07.1 Dyshormogenetic goitre
0.000 0.532 0.467
E07.0 Hypersecretion of calcitonin
0.000 0.532 0.467
E24.8 Other Cushing's syndrome
0.000 0.534 0.466
E34.8 Other specified endocrine disorders
0.000 0.534 0.466
E55 Vitamin D deficiency
0.000 0.538 0.462
E24.0 Pituitary-dependent Cushing's disease
0.000 0.541 0.458
E27.9 Disorder of adrenal gland, unspecified
0.000 0.543 0.456
E29 Testicular dysfunction
0.000 0.545 0.455
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.546 0.454
E24.3 Ectopic ACTH syndrome
0.000 0.546 0.454
E24.1 Nelson's syndrome
0.000 0.546 0.454
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.549 0.450
E07.8 Other specified disorders of thyroid
0.000 0.552 0.448
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.553 0.447
E22.8 Other hyperfunction of pituitary gland
0.000 0.555 0.445
E30.9 Disorder of puberty, unspecified
0.000 0.556 0.444
E30.8 Other disorders of puberty
0.000 0.556 0.444
E30.1 Precocious puberty
0.000 0.556 0.444
E30.0 Delayed puberty
0.000 0.556 0.444
E32.9 Disease of thymus, unspecified
0.000 0.556 0.444
E32.8 Other diseases of thymus
0.000 0.556 0.444
E32.1 Abscess of thymus
0.000 0.556 0.444
E32.0 Persistent hyperplasia of thymus
0.000 0.556 0.444
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.556 0.444
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.556 0.444
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.556 0.444
E21.2 Other hyperparathyroidism
0.000 0.565 0.434
E21.3 Hyperparathyroidism, unspecified
0.000 0.567 0.433
E07.9 Disorder of thyroid, unspecified
0.000 0.572 0.428
E22.0 Acromegaly and pituitary gigantism
0.000 0.576 0.424
E56 Other vitamin deficiencies
0.000 0.576 0.424
E23.6 Other disorders of pituitary gland
0.000 0.582 0.418
E34.5 Androgen resistance syndrome
0.000 0.583 0.417
E34.4 Constitutional tall stature
0.000 0.583 0.417
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.583 0.417
E34.1 Other hypersecretion of intestinal hormones
0.000 0.583 0.417
E26.0 Primary hyperaldosteronism
0.000 0.585 0.415
E20.1 Pseudohypoparathyroidism
0.000 0.587 0.413
E20.0 Idiopathic hypoparathyroidism
0.000 0.587 0.413
E34.9 Endocrine disorder, unspecified
0.000 0.590 0.410
E20.8 Other hypoparathyroidism
0.000 0.590 0.409
E26.8 Other hyperaldosteronism
0.000 0.592 0.408
E26.1 Secondary hyperaldosteronism
0.000 0.592 0.408
E61 Deficiency of other nutrient elements
0.000 0.593 0.407
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.599 0.401
E50 Vitamin A deficiency
0.000 0.599 0.401
E60 Dietary zinc deficiency
0.000 0.599 0.401
E59 Dietary selenium deficiency
0.000 0.599 0.401
E52 Niacin deficiency [pellagra]
0.000 0.599 0.401
E23.2 Diabetes insipidus
0.000 0.601 0.399
E55.9 Vitamin D deficiency, unspecified
0.000 0.607 0.393
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.617 0.383
E63 Other nutritional deficiencies
0.000 0.620 0.380
E34.3 Short stature, not elsewhere classified
0.000 0.623 0.377
E51 Thiamine deficiency
0.000 0.624 0.376
E23.1 Drug-induced hypopituitarism
0.000 0.625 0.375
E20.9 Hypoparathyroidism, unspecified
0.000 0.625 0.375
E27.8 Other specified disorders of adrenal gland
0.000 0.627 0.373
E44.1 Mild protein-energy malnutrition
0.000 0.628 0.371
E44.0 Moderate protein-energy malnutrition
0.000 0.628 0.371
E54 Ascorbic acid deficiency
0.000 0.636 0.363
E34.0 Carcinoid syndrome
0.000 0.642 0.358
E28.9 Ovarian dysfunction, unspecified
0.000 0.645 0.355
E28.8 Other ovarian dysfunction
0.000 0.645 0.355
E28.1 Androgen excess
0.000 0.645 0.355
E28.0 Oestrogen excess
0.000 0.645 0.355
E26.9 Hyperaldosteronism, unspecified
0.000 0.652 0.348
E29.9 Testicular dysfunction, unspecified
0.000 0.656 0.343
E58 Dietary calcium deficiency
0.000 0.658 0.342
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.660 0.340
E06.4 Drug-induced thyroiditis
0.000 0.661 0.339
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.661 0.339
E06.0 Acute thyroiditis
0.000 0.661 0.339
E65-E68 Obesity and other hyperalimentation
0.000 0.662 0.338
E55.0 Rickets, active
0.000 0.668 0.332
E56.1 Deficiency of vitamin K
0.000 0.673 0.327
E29.8 Other testicular dysfunction
0.000 0.673 0.326
E29.0 Testicular hyperfunction
0.000 0.673 0.326
E23.7 Disorder of pituitary gland, unspecified
0.000 0.675 0.325
E28.3 Primary ovarian failure
0.000 0.680 0.320
E06.5 Other chronic thyroiditis
0.000 0.681 0.319
E06.3 Autoimmune thyroiditis
0.000 0.685 0.315
E24.9 Cushing's syndrome, unspecified
0.000 0.693 0.307
E56.9 Vitamin deficiency, unspecified
0.000 0.696 0.304
E56.8 Deficiency of other vitamins
0.000 0.696 0.304
E56.0 Deficiency of vitamin E
0.000 0.696 0.304
E61.1 Iron deficiency
0.000 0.700 0.300
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.701 0.299
E61.9 Deficiency of nutrient element, unspecified
0.000 0.708 0.292
E61.8 Deficiency of other specified nutrient elements
0.000 0.708 0.292
E61.7 Deficiency of multiple nutrient elements
0.000 0.708 0.292
E61.6 Vanadium deficiency
0.000 0.708 0.292
E61.5 Molybdenum deficiency
0.000 0.708 0.292
E61.4 Chromium deficiency
0.000 0.708 0.292
E61.3 Manganese deficiency
0.000 0.708 0.292
E61.0 Copper deficiency
0.000 0.708 0.292
E61.2 Magnesium deficiency
0.000 0.709 0.291
E50.9 Vitamin A deficiency, unspecified
0.000 0.712 0.287
E50.8 Other manifestations of vitamin A deficiency
0.000 0.712 0.287
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.712 0.287
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.712 0.287
E50.5 Vitamin A deficiency with night blindness
0.000 0.712 0.287
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.712 0.287
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.712 0.287
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.712 0.287
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.712 0.287
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.712 0.287
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.712 0.287
E64.8 Sequelae of other nutritional deficiencies
0.000 0.712 0.287
E64.3 Sequelae of rickets
0.000 0.712 0.287
E64.2 Sequelae of vitamin C deficiency
0.000 0.712 0.287
E64.1 Sequelae of vitamin A deficiency
0.000 0.712 0.287
E64.0 Sequelae of protein-energy malnutrition
0.000 0.712 0.287
T50.9 Other and unspecified drugs, medicaments and biological substances
0.286 0.714 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.286 0.714 0.000
T39.1 4-Aminophenol derivatives
0.284 0.716 0.000
E28.2 Polycystic ovarian syndrome
0.000 0.716 0.284
T36-T50 Poisoning by drugs, medicaments and biological substances
0.283 0.717 0.000
E06.1 Subacute thyroiditis
0.000 0.718 0.282
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.280 0.720 0.000
E06.9 Thyroiditis, unspecified
0.000 0.722 0.277
E53 Deficiency of other B group vitamins
0.000 0.724 0.276
E23.0 Hypopituitarism
0.000 0.726 0.274
E63.8 Other specified nutritional deficiencies
0.000 0.727 0.272
E63.1 Imbalance of constituents of food intake
0.000 0.727 0.272
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.727 0.272
E51.9 Thiamine deficiency, unspecified
0.000 0.730 0.270
E51.8 Other manifestations of thiamine deficiency
0.000 0.730 0.270
E51.1 Beriberi
0.000 0.730 0.270
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.265 0.735 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.264 0.736 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.254 0.746 0.000
E63.9 Nutritional deficiency, unspecified
0.000 0.748 0.251
T50.8 Diagnostic agents
0.247 0.752 0.000
T40.2 Other opioids
0.247 0.753 0.000
E51.2 Wernicke's encephalopathy
0.000 0.755 0.245
N40-N51 Diseases of male genital organs
0.245 0.755 0.000
E67 Other hyperalimentation
0.000 0.757 0.243
E68 Sequelae of hyperalimentation
0.000 0.757 0.243
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.240 0.760 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.237 0.763 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.227 0.773 0.000
N49 Inflammatory disorders of male genital organs, not elsewhere classified
0.223 0.776 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.221 0.779 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.218 0.782 0.000
T40.4 Other synthetic narcotics
0.215 0.785 0.000
N45 Orchitis and epididymitis
0.213 0.787 0.000
T36 Poisoning by systemic antibiotics
0.212 0.788 0.000
T42.1 Iminostilbenes
0.212 0.788 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.210 0.790 0.000
T50.7 Analeptics and opioid receptor antagonists
0.205 0.795 0.000
T50.5 Appetite depressants
0.205 0.795 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.205 0.795 0.000
T50.0 Mineralocorticoids and their antagonists
0.205 0.795 0.000
E04 Other non-toxic goitre
0.000 0.796 0.204
T41 Poisoning by anaesthetics and therapeutic gases
0.203 0.797 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.202 0.798 0.000
T39.4 Antirheumatics, not elsewhere classified
0.201 0.799 0.000
T39.2 Pyrazolone derivatives
0.201 0.799 0.000
N42 Other disorders of prostate
0.198 0.802 0.000
E53.1 Pyridoxine deficiency
0.000 0.802 0.198
E53.0 Riboflavin deficiency
0.000 0.802 0.198
E14.9 Without complications
0.000 0.803 0.197
T50.4 Drugs affecting uric acid metabolism
0.197 0.803 0.000
N49.2 Inflammatory disorders of scrotum
0.196 0.804 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.195 0.805 0.000
T40.6 Other and unspecified narcotics
0.194 0.805 0.000
E11 Non-insulin-dependent diabetes mellitus
0.000 0.806 0.194
N41 Inflammatory diseases of prostate
0.194 0.806 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.190 0.810 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.190 0.810 0.000
T42.2 Succinimides and oxazolidinediones
0.190 0.810 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.190 0.810 0.000
T40.8 Lysergide [LSD]
0.190 0.810 0.000
T40.7 Cannabis (derivatives)
0.190 0.810 0.000
T40.3 Methadone
0.190 0.810 0.000
T40.0 Opium
0.190 0.810 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.188 0.811 0.000
T40.5 Cocaine
0.186 0.814 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.186 0.814 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.185 0.815 0.000
T47.2 Stimulant laxatives
0.184 0.816 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.184 0.816 0.000
N42.1 Congestion and haemorrhage of prostate
0.183 0.817 0.000
N41.0 Acute prostatitis
0.183 0.817 0.000
T50.1 Loop [high-ceiling] diuretics
0.183 0.817 0.000
E83 Disorders of mineral metabolism
0.178 0.817 0.005
N49.8 Inflammatory disorders of other specified male genital organs
0.182 0.818 0.000
N51 Disorders of male genital organs in diseases classified elsewhere
0.182 0.818 0.000
N45.0 Orchitis, epididymitis and epididymo-orchitis with abscess
0.181 0.819 0.000
T40.1 Heroin
0.179 0.821 0.000
T47.4 Other laxatives
0.179 0.821 0.000
N46 Male infertility
0.178 0.821 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.177 0.823 0.000
T47.6 Antidiarrhoeal drugs
0.177 0.823 0.000
T46.1 Calcium-channel blockers
0.177 0.823 0.000
N44 Torsion of testis
0.176 0.824 0.000
E53.9 Vitamin B deficiency, unspecified
0.000 0.825 0.175
E67.8 Other specified hyperalimentation
0.000 0.826 0.174
E67.3 Hypervitaminosis D
0.000 0.826 0.174
E67.2 Megavitamin-B6 syndrome
0.000 0.826 0.174
E67.1 Hypercarotenaemia
0.000 0.826 0.174
E67.0 Hypervitaminosis A
0.000 0.826 0.174
T42.0 Hydantoin derivatives
0.174 0.826 0.000
T42.3 Barbiturates
0.170 0.830 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.170 0.830 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.170 0.830 0.000
T47.7 Emetics
0.170 0.830 0.000
T47.5 Digestants
0.170 0.830 0.000
T47.3 Saline and osmotic laxatives
0.170 0.830 0.000
E11.6 With other specified complications
0.000 0.831 0.169
N49.1 Inflammatory disorders of spermatic cord, tunica vaginalis and vas deferens
0.168 0.832 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.168 0.832 0.000
N45.9 Orchitis, epididymitis and epididymo-orchitis without abscess
0.168 0.832 0.000
N41.1 Chronic prostatitis
0.168 0.832 0.000
T36.3 Macrolides
0.166 0.834 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.164 0.836 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.163 0.837 0.000
T46.7 Peripheral vasodilators
0.163 0.837 0.000
T47.0 Histamine H(2)-receptor antagonists
0.163 0.837 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.161 0.839 0.000
N49.9 Inflammatory disorder of unspecified male genital organ
0.160 0.840 0.000
N49.0 Inflammatory disorders of seminal vesicle
0.160 0.840 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.160 0.840 0.000
E65 Localised adiposity
0.000 0.840 0.160
T46.4 Angiotensin-converting-enzyme inhibitors
0.159 0.841 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.158 0.842 0.000
N42.0 Calculus of prostate
0.158 0.842 0.000
T36.4 Tetracyclines
0.156 0.844 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.155 0.845 0.000
T36.8 Other systemic antibiotics
0.154 0.845 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.153 0.846 0.000
E83.3 Disorders of phosphorus metabolism
0.152 0.847 0.001
T36.9 Systemic antibiotic, unspecified
0.152 0.848 0.000
T36.7 Antifungal antibiotics, systemically used
0.152 0.848 0.000
T36.6 Rifamycins
0.152 0.848 0.000
T36.5 Aminoglycosides
0.152 0.848 0.000
T36.2 Chloramphenicol group
0.152 0.848 0.000
T49.9 Topical agent, unspecified
0.151 0.849 0.000
T49.8 Other topical agents
0.151 0.849 0.000
T49.7 Dental drugs, topically applied
0.151 0.849 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.151 0.849 0.000
T49.5 Ophthalmological drugs and preparations
0.151 0.849 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.151 0.849 0.000
T49.3 Emollients, demulcents and protectants
0.151 0.849 0.000
T49.2 Local astringents and local detergents
0.151 0.849 0.000
T49.1 Antipruritics
0.151 0.849 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.149 0.850 0.000
N42.8 Other specified disorders of prostate
0.149 0.851 0.000
T42.4 Benzodiazepines
0.148 0.852 0.000
E04.8 Other specified non-toxic goitre
0.000 0.854 0.146
T41.5 Therapeutic gases
0.145 0.854 0.000
T41.4 Anaesthetic, unspecified
0.145 0.854 0.000
T41.3 Local anaesthetics
0.145 0.854 0.000
T41.2 Other and unspecified general anaesthetics
0.145 0.854 0.000
T41.1 Intravenous anaesthetics
0.145 0.854 0.000
T41.0 Inhaled anaesthetics
0.145 0.854 0.000
E11.7 With multiple complications
0.000 0.854 0.145
E04.9 Non-toxic goitre, unspecified
0.000 0.855 0.145
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.145 0.855 0.000
E11.2 With renal complications
0.000 0.856 0.144
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.142 0.858 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.141 0.859 0.000
N50 Other disorders of male genital organs
0.141 0.859 0.000
N42.3 Dysplasia of prostate
0.140 0.860 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.140 0.860 0.000
T37.5 Antiviral drugs
0.140 0.860 0.000
T37.4 Anthelminthics
0.140 0.860 0.000
T37.3 Other antiprotozoal drugs
0.140 0.860 0.000
T37.1 Antimycobacterial drugs
0.140 0.860 0.000
T37.0 Sulphonamides
0.140 0.860 0.000
N41.3 Prostatocystitis
0.139 0.861 0.000
E83.9 Disorder of mineral metabolism, unspecified
0.136 0.861 0.003
N51.2 Balanitis in diseases classified elsewhere
0.136 0.864 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.134 0.866 0.000
N50.9 Disorder of male genital organs, unspecified
0.133 0.867 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.132 0.868 0.000
T48.4 Expectorants
0.132 0.868 0.000
T48.3 Antitussives
0.132 0.868 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.132 0.868 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.132 0.868 0.000
T48.0 Oxytocic drugs
0.132 0.868 0.000
E83.8 Other disorders of mineral metabolism
0.128 0.869 0.004
E83.2 Disorders of zinc metabolism
0.128 0.869 0.004
E83.0 Disorders of copper metabolism
0.128 0.869 0.004
E11.1 With ketoacidosis
0.000 0.869 0.131
N51.8 Other disorders of male genital organs in diseases classified elsewhere
0.130 0.869 0.000
N51.1 Disorders of testis and epididymis in diseases classified elsewhere
0.130 0.869 0.000
N51.0 Disorders of prostate in diseases classified elsewhere
0.130 0.869 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.130 0.870 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.127 0.873 0.000
E11.8 With unspecified complications
0.000 0.873 0.127
E11.5 With peripheral circulatory complications
0.000 0.874 0.126
T39.0 Salicylates
0.122 0.878 0.000
T48.5 Anti-common-cold drugs
0.119 0.881 0.000
E53.8 Deficiency of other specified B group vitamins
0.000 0.881 0.119
E29.1 Testicular hypofunction
0.001 0.882 0.117
T36.0 Penicillins
0.116 0.884 0.000
T43.2 Other and unspecified antidepressants
0.115 0.885 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.115 0.885 0.000
E04.0 Non-toxic diffuse goitre
0.000 0.886 0.114
N41.2 Abscess of prostate
0.114 0.886 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.112 0.888 0.000
E11.3 With ophthalmic complications
0.000 0.888 0.112
T45.4 Iron and its compounds
0.111 0.889 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.111 0.889 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.111 0.889 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.111 0.889 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.111 0.889 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.111 0.889 0.000
T44.0 Anticholinesterase agents
0.111 0.889 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.109 0.891 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.107 0.893 0.000
N41.8 Other inflammatory diseases of prostate
0.106 0.893 0.000
E11.0 With coma
0.000 0.893 0.106
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.104 0.896 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.104 0.896 0.000
T45.8 Other primarily systemic and haematological agents
0.104 0.896 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.104 0.896 0.000
T45.6 Fibrinolysis-affecting drugs
0.104 0.896 0.000
T45.3 Enzymes, not elsewhere classified
0.104 0.896 0.000
T45.2 Vitamins, not elsewhere classified
0.103 0.897 0.000
N42.2 Atrophy of prostate
0.103 0.897 0.000
T38.9 Other and unspecified hormone antagonists
0.102 0.898 0.000
T38.7 Androgens and anabolic congeners
0.102 0.898 0.000
T38.5 Other oestrogens and progestogens
0.102 0.898 0.000
T38.4 Oral contraceptives
0.102 0.898 0.000
T38.2 Antithyroid drugs
0.102 0.898 0.000
N43 Hydrocele and spermatocele
0.102 0.898 0.000
T43.9 Psychotropic drug, unspecified
0.100 0.899 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.096 0.903 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.095 0.904 0.000
T38.0 Glucocorticoids and synthetic analogues
0.095 0.905 0.000
N50.0 Atrophy of testis
0.092 0.907 0.000
T45.5 Anticoagulants
0.091 0.909 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.088 0.912 0.000
N42.9 Disorder of prostate, unspecified
0.088 0.912 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.086 0.914 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.086 0.914 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.085 0.914 0.000
T38.1 Thyroid hormones and substitutes
0.084 0.916 0.000
T45.0 Antiallergic and antiemetic drugs
0.084 0.916 0.000
E66 Obesity
0.000 0.916 0.084
T43.6 Psychostimulants with abuse potential
0.081 0.919 0.000
E11.4 With neurological complications
0.000 0.920 0.080
N43.2 Other hydrocele
0.080 0.920 0.000
N43.0 Encysted hydrocele
0.075 0.925 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.070 0.930 0.000
N43.1 Infected hydrocele
0.068 0.931 0.000
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.933 0.067
K90-K93 Other diseases of the digestive system
0.000 0.934 0.066
E04.1 Non-toxic single thyroid nodule
0.000 0.936 0.064
E83.4 Disorders of magnesium metabolism
0.061 0.936 0.002
N43.4 Spermatocele
0.062 0.937 0.000
E66.1 Drug-induced obesity
0.000 0.940 0.060
E66.0 Obesity due to excess calories
0.000 0.942 0.058
T43.0 Tricyclic and tetracyclic antidepressants
0.057 0.943 0.000
E04.2 Non-toxic multinodular goitre
0.000 0.944 0.056
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.952 0.048
N50.1 Vascular disorders of male genital organs
0.048 0.952 0.000
N41.9 Inflammatory disease of prostate, unspecified
0.042 0.958 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.